CFO4Life Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,178
| Closed | -$613K | – | 226 |
|
2024
Q3 | $613K | Sell |
1,178
-21
| -2% | -$10.9K | 0.11% | 108 |
|
2024
Q2 | $650K | Sell |
1,199
-6
| -0.5% | -$3.25K | 0.12% | 94 |
|
2024
Q1 | $625K | Sell |
1,205
-17
| -1% | -$8.81K | 0.11% | 99 |
|
2023
Q4 | $576K | Sell |
1,222
-81
| -6% | -$38.2K | 0.11% | 105 |
|
2023
Q3 | $567K | Sell |
1,303
-29
| -2% | -$12.6K | 0.13% | 94 |
|
2023
Q2 | $592K | Buy |
1,332
+47
| +4% | +$20.9K | 0.13% | 89 |
|
2023
Q1 | $591K | Sell |
1,285
-55
| -4% | -$25.3K | 0.13% | 87 |
|
2022
Q4 | $687K | Sell |
1,340
-3
| -0.2% | -$1.54K | 0.15% | 81 |
|
2022
Q3 | $610K | Buy |
1,343
+103
| +8% | +$46.8K | 0.16% | 71 |
|
2022
Q2 | $596K | Buy |
+1,240
| New | +$596K | 0.15% | 74 |
|
2021
Q1 | – | Sell |
-1,528
| Closed | -$491K | – | 146 |
|
2020
Q4 | $491K | Buy |
1,528
+38
| +3% | +$12.2K | 0.14% | 81 |
|
2020
Q3 | $400K | Buy |
1,490
+517
| +53% | +$139K | 0.14% | 90 |
|
2020
Q2 | $256K | Buy |
+973
| New | +$256K | 0.1% | 104 |
|